Filing Details

1.

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 

Johnson & Johnson

EIN:  22-1024240

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

3.

SEC USE ONLY

 

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

New Jersey

 

 

 

NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH

5.

SOLE VOTING POWER

          -0-

 

6.

SHARED VOTING POWER

          2,449,183

 

7.

SOLE DISPOSITIVE POWER

          -0-

 

8.

SHARED DISPOSITIVE POWER

          2,449,183

 

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

          2,449,183

 

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

[  ]

 

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

          15.0%*

 

12.

TYPE OF REPORTING PERSON

          CO

 

1.

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 

Johnson & Johnson Innovation-JJDC, Inc.

EIN:  22-2007137

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

3.

SEC USE ONLY

 

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

New Jersey

 

 

 

 

NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH

5.

SOLE VOTING POWER

          -0-

 

6.

SHARED VOTING POWER

          2,449,183

 

7.

SOLE DISPOSITIVE POWER

          -0-

 

8.

SHARED DISPOSITIVE POWER

          2,449,183

 

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

          2,449,183

 

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

[  ]

 

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

          15.0%*

 

12.

TYPE OF REPORTING PERSON

          CO

 

ITEM 1(a)

NAME OF ISSUER:

Protagonist Therapeutics, Inc.

ITEM 1(b)

ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

521 Cottonwood Drive, Suite 100

Malpitas, CA  95035-7404

ITEM 2(a)

NAME OF PERSON FILING:

This statement is being filed by Johnson & Johnson, a New Jersey corporation ("J&J"), and Johnson & Johnson Innovation-JJDC, Inc., a New Jersey corporation ("JJDC").  JJDC is a wholly-owned subsidiary of J&J. The securities reported herein as being held by J&J and JJDC are directly beneficially owned by JJDC.  J&J may be deemed to indirectly beneficially own the securities that are directly beneficially owned by JJDC.

ITEM 2(b)

ADDRESS OF PRINCIPAL BUSINESS OFFICE:

One Johnson & Johnson Plaza

New Brunswick, NJ 08933

ITEM 2(c)

CITIZENSHIP:

J&J:  New Jersey

JJDC:  New Jersey

ITEM 2(d)

TITLE OF CLASS OF SECURITIES:

Common Stock, $.00001 par value per share ("Common Stock")

ITEM 2(e)

CUSIP NUMBER:

74366E102

ITEM 3

STATEMENTS FILED PURSUANT TO RULES 13D-1(B) OR 13D-2(B) OR (C):

Not applicable.

ITEM 4

OWNERSHIP:

The information set forth in Rows 5 through 9 and 11 of the cover pages of this Schedule 13G is incorporated herein by reference.

ITEM 5

OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:

Not applicable.

ITEM 6

OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:

Not applicable.

ITEM 7

IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT COMPANY:

Not applicable.

ITEM 8

IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:

Not applicable.

ITEM 9

NOTICE OF DISSOLUTION OF GROUP:

Not applicable.

ITEM 10

CERTIFICATION:

By signing below the undersigned certify that, to the best of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.